Differentiation of spontaneous and induced mammary adenocarcinomas of the rat by gene expression profiling

Experimental and Toxicologic Pathology

Volumn 58, Issue 2-3, 2006, Pages 151-161

  Marxfeld, Heike ^a,b   Grenet, Olivier ^a   Bringel, Josiane ^a   Staedtler, Frank ^a   Harleman, Johannes H ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

FGF 3; Gene expression profiling; Mammary adenocarcinoma; Rat; RMT 1

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; MARKER GENE; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION;

EID: 33750305219     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2006.06.008     Document Type: Article

References (24)

1. Applied Biosystems: 〈http://www.appliedbiosystems.com/catalog〉.
2. Beckmann M.W., Niederacher D., Schnurch H.G., et al. Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med 75 (1997) 429-439
3. Bouras T., Southey M.C., Chang A.C., et al. Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Res 62 (2002) 1289-1295
4. Brisken C., Heineman A., Chavarria T., et al. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 14 (2000) 650-654
5. Chiou S., Yoo J., Loh K.C., et al. Identification of rat mammary tumor-1 gene (RMT-1), which is highly expressed in rat mammary tumors. Cancer Lett 174 (2001) 45-55
6. D'Cruz C.M., Moody S.E., Master S.R., et al. Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 16 (2002) 2034-2051
7. Desai K.V., Xiao N., Wang W., et al. Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc Natl Acad Sci USA 99 (2002) 6967-6972 [Erratum in: Proc Natl Acad Sci USA 2002; 99(15): 10227]
8. Fletcher G.C., Patel S., Tyson K., et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J Cancer 88 (2003) 579-585
9. Gordon M.K., Gerecke D.R., and Olsen B.R. Type XII collagen: distinct extracellular matrix component discovered by cDNA cloning. Proc Natl Acad Sci USA 84 (1987) 6040-6044
10. Grasso P., and Price S. The cancer bioassay. In: Kitchin K.T. (Ed). Carcinogenicity testing, predicting, and interpreting chemical effects (1999), Marcel Dekker Inc., New York 1-20
11. Holden D.P., Cartwright J.E., Nussey S.S., et al. Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine. Circulation 108 (2003) 1575-1580 [Epub 2003, September 8]
12. Iruela-Arispe M.L., Carpizo D., and Luque A. ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci 995 (2003) 183-190
13. Leung K.H., Pippalla V., Kreutter A., et al. Functional effects of FGF-13 on human lung fibroblasts, dermal microvascular endothelial cells, and aortic smooth muscle cells. Biochem Biophys Res Commun 250 (1998) 137-142 [Erratum in: Biochem Biophys Res Commun 1998; 251(2): 667]
14. Macinnes J.I., Nozik E.S., and Kurtz D.T. Tissue-specific expression of the rat alpha 2u globulin gene family. Mol Cell Biol 6 (1986) 3563-3567
15. Marxfeld H., Staedtler F., and Harleman J.H. Gene expression in fibroadenomas of the rat mammary gland in contrast to spontaneous adenocarcinomas and normal mammary gland. Exp Toxic Pathol 58 (2006) 145-150
16. Menashi S., Serova M., Ma L., et al. Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells. Cancer Res 63 (2003) 7575-7580
17. Naidu R., Wahab N.A., Yadav M., et al. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction. Int J Mol Med 8 (2001) 193-198
18. Quiagen: 〈www.quiagen.com〉.
19. Relf M., Lejeune S., Scott P.A., et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 57 (1997) 963-969
20. Russo J., Russo I.H., van Zwieten J.W., Rogers A.E., and Gusterson B.A. Classification of neoplastic and nonneoplastic lesions of the rat mammary gland. In: Jones T.C., Mohr U., and Hunt R.D. (Eds). Integument and mammary glands, monographs on pathology of laboratory animals (1989), Springer, New York
21. Shan L., Yu M., and Snyderwine E.G. Gene expression profiling of chemically induced rat mammary gland cancer. Carcinogenesis 26 (2005) 503-509 [Epub 2004, November 4]
22. Ueda S., Kuwabara I., and Liu F.T. Suppression of tumor growth by galectin-7 gene transfer. Cancer Res 64 (2004) 5672-5676
23. Xie W.F., Zhang X., and Sandell L.J. The 2.2-kb promoter of cartilage-derived retinoic acid-sensitive protein controls gene expression in cartilage and embryonic mammary buds of transgenic mice. Matrix Biol 19 (2000) 501-509
24. Yahata T., Takedatsu H., Dunwoodie S.L., et al. Cloning of mouse Cited4, a member of the CITED family p300/CBP-binding transcriptional coactivators: induced expression in mammary epithelial cells. Genomics 80 (2002) 601-613